Romolo Daniele DE SIATI

Dr. Romolo Daniele DE SIATI

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RSRomolo Daniele DE SIATI
Romolo Daniele DE SIATI
FRFlora Rosenzweig
Flora Rosenzweig
GGGuillaume Gersdorff
Guillaume Gersdorff
AGAnaïs Gregoire
Anaïs Gregoire
PRPhilippe Rombaux
Philippe Rombaux
NDNaïma Deggouj
Naïma Deggouj
Auditory neuropathy spectrum disorder (ANSD) refers to a range of hearing impairments characterized by deteriorated speech perception, despite relatively preserved pure-tone detection thresholds. Affected individuals usually present with abnormal auditory brainstem responses (ABRs), but normal otoacoustic emissions (OAEs). These electrophysiological characteristics have led to the hypothesis that ANSD may be caused by various dysfunctions at the cochlear inner hair cell (IHC) and spiral ganglion neuron (SGN) levels, while the activity of outer hair cells (OHCs) is preserved, resulting in discrepancies between pure-tone and speech comprehension thresholds. The exact prevalence of ANSD remains unknown; clinical findings show a large variability among subjects with hearing impairment ranging from mild to profound hearing loss. A wide range of prenatal and postnatal etiologies have been proposed. The study of genetics and of the implicated sites of lesion correlated with clinical findings have also led to a better understanding of the molecular mechanisms underlying the various forms of ANSD, and may guide clinicians in better screening, assessment and treatment of ANSD patients. Besides OAEs and ABRs, audiological assessment includes stapedial reflex measurements, supraliminal psychoacoustic tests, electrocochleography (ECochG), auditory steady-state responses (ASSRs) and cortical auditory evoked potentials (CAEPs). Hearing aids are indicated in the treatment of ANSD with mild to moderate hearing loss, whereas cochlear implantation is the first choice of treatment in case of profound hearing loss, especially in case of IHC presynaptic disorders, or in case of poor auditory outcomes with conventional hearing aids.

1 June 2021 in International Journal of Audiology
Verified
Journal Article
Closed access
DPDaniela Parrino
Daniela Parrino
Andrea FrosoliniAndrea Frosolini
Andrea Frosolini
CGChiara Gallo
Chiara Gallo
RSRomolo Daniele DE SIATI
Romolo Daniele DE SIATI
GSGiacomo Spinato
Giacomo Spinato
Cosimo de FilippisCosimo de Filippis
Cosimo de Filippis
To ensure the safety and quality of vaccines, especially the newest RNA-vaccines against COVID-19, is one of the World Health Organization’s current highest priorities.Case description.We report th...

10 May 2023 in Audiology Research
Verified
Journal Article
Open access
PDF file
Laurence JONARDLaurence JONARD
Laurence JONARD
DBDavide Brotto
Davide Brotto
MMMiguel Angel Moreno-Pelayo
Miguel Angel Moreno-Pelayo
Ignacio del CastilloIgnacio del Castillo
Ignacio del Castillo
HKHannie Kremer
Hannie Kremer
SMsandrine marlin
sandrine marlin
The cause of childhood hearing impairment (excluding infectious pathology of the middle ear) can be extrinsic (embryofoetopathy, meningitis, trauma, drug ototoxicity, noise trauma, etc